SUPPORTING STATEMENT FOR THE
COLLECTION OF INFORMATION REQUIREMENTS OF THE
BLOODBORNE PATHOGENS STANDARD (29 CFR 1910.1030)1
(OFFICE OF MANAGEMENT AND BUDGET (OMB)
CONTROL NUMBER 1218-0180) (March 2015)
A. JUSTIFICATION
1. Explain the circumstances that make the collection of information necessary. Identify any legal or administrative requirements that necessitate the collection. Attach a copy of the appropriate section of each statute and regulation mandating or authorizing the collection of information.
The main objective of the Occupational Safety and Health Act (OSH Act) is to “assure so far as possible every working man and woman in the Nation safe and healthful working conditions and to preserve our human resources” (29 U.S.C. 651). To achieve this objective, the OSH Act specifically authorizes “the development and promulgation of occupational safety and health regulations” (29 U.S.C. 651).
To protect employee health, the OSH Act authorizes the Occupational Safety and Health Administration (OSHA) to develop standards that provide for “monitoring or measuring employee exposure” to occupational hazards and “prescribe the type and frequency of medical examinations and other tests which shall be made available [by the employer] to employees exposed to such hazards in order to most effectively determine whether the health of such employees is adversely affected by such exposure” (29 U.S.C. 655). In addition, the OSH Act mandates that “[e]ach employer shall make, keep and preserve, and make available to the Secretary [of Labor] . . . such records regarding [his/her] activities relating to this Act as the Secretary . . . may prescribe by regulation as necessary or appropriate for the enforcement of this Act or for developing information regarding the causes and prevention of occupational accidents and illnesses” (29 U.S.C. 657). In addition, the OSH Act directs OSHA to “issue regulations requiring employers to maintain accurate records of employee exposure to potentially toxic materials or other harmful physical agents which are required to be monitored and measured," and further specifies that such regulations provide “for each employee or former employee to have access to such records as will indicate [their] own exposure to toxic materials or harmful physical agents” (29 U.S.C. 657). The OSH Act states further that “[t]he Secretary . . . shall . . . prescribe such rules and regulations as [he/she] may deem necessary to carry out [his/her] responsibilities under this Act, including rules and regulations dealing with the inspection of an employer’s establishment” (29 U.S.C. 651).
Under the authority granted by the OSH Act, the Occupational Safety and Health Act (“OSHA” or “Agency”) published a health standard governing employee exposure to Bloodborne Pathogens at 29 CFR 1910.1030, 1915.1030 (the “Standard”). The basis for this Standard is a determination by the Assistant Secretary for OSHA that occupational exposure to bloodborne pathogens can result in infections. These pathogens include, but are not limited to, the hepatitis B virus or the human immunodeficiency virus. These infections can lead to serious clinical illness which may result in death. Additionally, on November 6, 2000, the Needlestick Safety and Prevention Act (NSPA), was signed into law (Pub. L. 106-430), as a result of the growing concern over bloodborne pathogens exposures resulting from sharps injuries and in response to technological developments that increase employee protections. On January 18, 2001, OSHA published a Direct Final Rule to conform to the requirements of NSPA. The collection of information requirements resulting from the NSPA include: modifying the existing requirements for revising and updating the exposure control plan; soliciting of employee input for selecting safer medical devices; and recordkeeping. The collection of information requirements contained in the Standard, including the NSPA requirements, are fully discussed under items 2 and 12.
2. Indicate how, by whom, and for what purpose the information is to be used. Except for a new collection, indicate the actual use the agency has made of the information received from the current collection.
Collections of information contained in this Standard include a written exposure control plan, documentation of employees’ hepatitis B vaccinations and post exposure evaluations and follow-up medical visits, labeling, training records, recordkeeping and a sharps injury log. Information generated in accordance with these provisions provides the employer and the employee with means to provide protection from the adverse health effects associated with occupational exposure to bloodborne pathogens.
A. Exposure control plan (§1910.1030(c)(1))
§1910.1030(c)(1)(i) - Each employer having an employee(s) with occupational exposure2 as defined by paragraph (b) of this section shall establish a written Exposure Control Plan designed to eliminate or minimize employee exposure.
§1910.1030(c)(1)(ii) - The Exposure Control Plan shall contain at least the following elements:
§1910.1030(c)(1)(ii)(A) - The exposure determination required by paragraph (c)(2),
§1910.1030(c)(1)(ii)(B) - The schedule and method of implementation for paragraphs (d) Methods of Compliance, (e) HIV and HBV Research Laboratories and Production Facilities, (f) Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-up, (g) Communication of Hazards to Employees, and (h) Recordkeeping, of this standard, and
§1910.1030(c)(1)(ii)(C) - The procedure for the evaluation of circumstances surrounding exposure incidents as required by paragraph (f)(3)(i) of this standard.
§1910.1030(c)(1)(iii) - Each employer shall ensure that a copy of the Exposure Control Plan is accessible to employees in accordance with 29 CFR 1910.1020(e).
§1910.1030(c)(1)(iv) - The Exposure Control Plan shall be reviewed and updated at least annually and whenever necessary to reflect new or modified tasks and procedures which affect occupational exposure and to reflect new or revised employee positions with occupational exposure. The review and update of such plans shall also:
§1910.1030(c)(1)(iv)(A) – Reflect changes in technology that eliminate or reduce exposure to bloodborne pathogens; and
§1910.1030(c)(1)(iv)(B) - Document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure.
§1910.1030(c)(1)(v) - An employer, who is required to establish an Exposure Control Plan shall solicit input from non-managerial employees responsible for direct patient care who are potentially exposed to injuries from contaminated sharps in the identification, evaluation, and selection of effective engineering and work practice controls and shall document the solicitation in the Exposure Control Plan.
§1910.1030(c)(1)(vi) - The Exposure Control Plan shall be made available to the Assistant Secretary and the Director upon request for examination and copying.
Purpose: The purpose of the Exposure Control Plan is to identify those tasks and procedures where occupational exposure may occur and to identify the positions whose duties include those tasks and procedures identified with occupational exposure. Additionally, this requirement is to assure that all new tasks and procedures are evaluated in order to determine whether they will result in occupational exposure. The review also assures evaluation and implementation of safer medical devices. Employee input into this process can serve to assist the employer in overcoming obstacles to the successful implementation of control measures.
Exposure determination (§1910.1030(c)(2)) - Each employer who has an employee(s) with occupational exposure as defined by paragraph (b) of this section shall prepare an exposure determination. This exposure determination shall contain the following:
§1910.1030(c)(2)(i)(A) - A list of all job classifications in which all employees in those job classifications have occupational exposure;
§1910.1030(c)(2)(i)(B) - A list of job classifications in which some employees have occupational exposure, and
§1910.1030(c)(2)(i)(C) - A list of all tasks and procedures or groups of closely related task and procedures in which occupational exposure occurs and that are performed by employees in job classifications listed in accordance with the provisions of paragraph (c)(2)(i)(B) of this standard.
Purpose: To assure that the workers who hold these job classifications are included in the training program, are provided with personal protective equipment, are provided with post exposure follow-up where appropriate, are included in the HBV vaccination program, and receive all other protection afforded by this standard.
B. Housekeeping (§1910.1030(d)(4))
General (§1910.1030(d)(4)(i)) - Employers shall ensure that the worksite is maintained in a clean and sanitary condition. The employer shall determine and implement an appropriate written schedule for cleaning and method of decontamination based upon the location within the facility, type of surface to be cleaned, type of soil present, and tasks or procedures being performed in the area.
Purpose: Assist in ensuring that routine cleaning, as recommended by CDC, is performed and that the method of decontamination deemed appropriate by the employer is followed. Additionally, the workers can utilize the schedule to determine when such cleaning should be done and what method they should use to properly accomplish the task.
C. Laundry (§1910.1030(d)(4)(iv))
§1910.1030(d)(4)(iv)(A) - Contaminated laundry shall be handled as little as possible with a minimum of agitation.
§1910.1030(d)(4)(iv)(A)(2) - Contaminated laundry shall be placed and transported in bags or containers labeled or color-coded in accordance with paragraph (g)(1)(i) of this standard. When a facility utilizes Universal Precautions in the handling of all soiled laundry, alternative labeling or color-coding is sufficient if it permits all employees to recognize the containers as requiring compliance with Universal Precautions.
§1910.1030(d)(4)(iv)(C) - When a facility ships contaminated laundry off-site to a second facility which does not utilize Universal Precautions in the handling of all laundry, the facility generating the contaminated laundry must place such laundry in bags or containers which are labeled or color-coded in accordance with paragraph (g)(1)(i).
Purpose: Placing and transporting contaminated laundry in labeled or color-coded bags or containers prevents inadvertent exposure by warning employees of the bag/container’s contaminated contents.
D. HIV and HBV research laboratories and production facilities (§1910.1030(e))
§1910.1030(e)(2)(ii)(B) - Contaminated materials that are to be decontaminated at a site away from the work area shall be placed in a durable, leak proof, labeled or color-coded container that is closed before being removed from the work area.
§1910.1030(e)(2)(ii)(C) Access to the work area shall be limited to authorized persons. Written policies and procedures shall be established whereby only persons who have been advised of the potential biohazard, who meet any specific entry requirements, and who comply with all entry and exit procedures shall be allowed to enter the work areas and animal rooms.
§1910.1030(e)(2)(ii)(M) - A biosafety manual shall be prepared or adopted and periodically reviewed and updated at least annually or more often if necessary. Personnel shall be advised of potential hazards, shall be required to read instructions on practices and procedures, and shall be required to follow them.
Purpose: Placing and transporting contaminated materials in labeled or color-coded container prevents inadvertent exposure by warning workers of the container’s contaminated contents. Only those individuals who have met specialized training requirements have access to this work area. The biosafety manual serves as a reference and assists in preventing exposure by identifying hazards and practices and procedures to be followed. Periodic review and update assures that the manual reflects the work setting’s current hazards, practices, and procedures.
E. Hepatitis B vaccination and post-exposure evaluation and follow-up (§1910.1030(f))
§1910.1030(f)(1)(i) - The employer shall make available the hepatitis B vaccine and vaccination series to all employees who have occupational exposure, and post-exposure evaluation and follow-up to all employees who have had an exposure incident.
§1910.1030(f)(1)(ii) - The employer shall ensure that all medical evaluations and procedures including the hepatitis B vaccine and vaccination series and post-exposure evaluation and follow-up, including prophylaxis, are:
§1910.1030(f)(1)(ii)(A) - Made available at no cost to the employee;
§1910.1030(f)(1)(ii)(D) - Provided according to recommendations of the U.S. Public Health Service current at the time these evaluations and procedures take place, except as specified by this paragraph (f).
Hepatitis B vaccination (§1910.1030(f)(2))
§1910.1030(f)(2)(i) - Hepatitis B vaccination shall be made available after the employee has received the training required in paragraph (g)(2)(vii)(I) and within 10 working days of initial assignment to all employees who have occupational exposure unless the employee has previously received the complete hepatitis B vaccination series, antibody testing has revealed that the employee is immune, or the vaccine is contraindicated for medical reasons.
§1910.1030(f)(2)(iii) - If the employee initially declines hepatitis B vaccination but at a later date while still covered under the standard decides to accept the vaccination, the employer shall make available hepatitis B vaccination at that time.
§1910.1030(f)(2)(iv) - The employer shall assure that employees who decline to accept hepatitis B vaccination offered by the employer sign the statement in Appendix A.
§1910.1030(f)(2)(v) - If a routine booster dose(s) of hepatitis B vaccine is recommended by the U.S. Public Health Service at a future date, such booster dose(s) shall be made available in accordance with section (f)(1)(ii).
Purpose: Hepatitis B vaccination is made available to eliminate or minimize risk of contracting hepatitis B through exposure, particularly when other controls inadequately protect or the worker is inadvertently or unknowingly exposed. Additionally, assures that workers who are initially reluctant to accept vaccination but who later change their minds as the result of information or experiences are accorded the opportunity to receive vaccination. The declination form encourages greater participation in the vaccination program by reiterating that a worker declining the hepatitis B vaccination remains at risk of acquiring hepatitis B. Also allows employers to easily determine who is not vaccinated so that resources can be directed toward improving the acceptance rate of the vaccination program, and assists compliance officers in enforcing training and vaccination requirements.
Post-exposure evaluation and follow-up (§1910.1030(f)(3)) - Following a report of an exposure incident, the employer shall make immediately available to the exposed employee a confidential medical evaluation and follow-up, including at least the following elements:
§1910.1030(f)(3)(i) - Documentation of the route(s) of exposure, and the circumstances under which the exposure incident occurred;
§1910.1030(f)(3)(ii) - Identification and documentation of the source individual, unless the employer can establish that identification is infeasible or prohibited by state or local law;
§1910.1030(f)(3)(ii)(A) - The source individual's blood shall be tested as soon as feasible and after consent is obtained in order to determine HBV and HIV infectivity. If consent is not obtained, the employer shall establish that legally required consent cannot be obtained. When the source individual's consent is not required by law, the source individual's blood, if available, shall be tested and the results documented.
§1910.1030(f)(3)(ii)(B) - When the source individual is already known to be infected with HBV or HIV, testing for the source individual's known HBV or HIV status need not be repeated.
§1910.1030(f)(3)(ii)(C) - Results of the source individual's testing shall be made available to the exposed employee, and the employee shall be informed of applicable laws and regulations concerning disclosure of the identity and infectious status of the source individual.
§1910.1030(f)(3)(iii) - Collection and testing of blood for HBV and HIV serological status;
§1910.1030(f)(3)(iii)(A) - The exposed employee's blood shall be collected as soon as feasible and tested after consent is obtained.
§1910.1030(f)(3)(iii)(B) - If the employee consents to baseline blood collection, but does not give consent at that time for HIV serologic testing, the sample shall be preserved for at least 90 days. If, within 90 days of the exposure incident, the employee elects to have the baseline sample tested, such testing shall be done as soon as feasible.
§1910.1030(f)(3)(iv) - Post-exposure prophylaxis, when medically indicated, as recommended by the U.S. Public Health Service;
§1910.1030(f)(3)(v) - Counseling; and
§1910.1030(f)(3)(vi) - Evaluation of reported illnesses.
Purpose: This documentation allows the employer to receive feedback regarding the circumstances of worker exposures, and the information collected can then be used to focus efforts on decreasing or eliminating specific circumstances or routes of exposure. Testing for the source individual’s infectious status provides exposed workers with information that will assist them in decisions regarding testing of their own blood, complying with other elements of post-exposure management, and using precautions to prevent transmission to their sexual partners or, in the case of pregnancy, to their fetuses. Such testing also assists the healthcare professional in deciding on appropriate follow-up. Counseling of exposed employees is a vital component of post-exposure follow up procedures and that counseling concerning infection status, including results of and interpretation of all tests will assist the worker in understanding the potential risk of infection and in making decisions regarding the protection personal contacts.
Information provided to the healthcare professional (§1910.1030(f)(4))
§1910.1030(f)(4)(i) - The employer shall ensure that the healthcare professional responsible for the employee's Hepatitis B vaccination is provided a copy of this regulation.
§1910.1030(f)(4)(ii) - The employer shall ensure that the healthcare professional evaluating an employee after an exposure incident is provided the following information:
§1910.1030(f)(4)(ii)(A) - A copy of this regulation;
§1910.1030(f)(4)(ii)(B) - A description of the exposed employee's duties as they relate to the exposure incident;
§1910.1030(f)(4)(ii)(C) - Documentation of the route(s) of exposure and circumstances under which exposure occurred;
§1910.1030(f)(4)(ii)(D) - Results of the source individual's blood testing, if available; and
§1910.1030(f)(4)(ii)(E) - All medical records relevant to the appropriate treatment of the employee including vaccination status which are the employer's responsibility to maintain.
Purpose: The purpose of providing this information is to inform the Healthcare Professional of the requirements of the standard. This information, which represents the minimum necessary for proper follow-up care, enables the Healthcare Professional to understand the worker's duties, the circumstances of the exposure incident, the source individual's infectious status, the worker's Hepatitis B vaccination status and other worker medical information. This information is essential to follow-up evaluation so that a determination can be made regarding whether prophylaxis or medical treatment is indicated.
Healthcare professional’s written opinion (§1910.1030(f)(5)) - The employer shall obtain and provide the employee with a copy of the evaluating healthcare professional's written opinion within 15 days of the completion of the evaluation.
§1910.1030(f)(5)(i) - The healthcare professional's written opinion for Hepatitis B vaccination shall be limited to whether Hepatitis B vaccination is indicated for an employee, and if the employee has received such vaccination.
§1910.1030(f)(5)(ii) - The healthcare professional's written opinion for post-exposure evaluation and follow-up shall be limited to the following information:
§1910.1030(f)(5)(ii)(A) - That the employee has been informed of the results of the evaluation; and
§1910.1030(f)(5)(ii)(B) - That the employee has been told about any medical conditions resulting from exposure to blood or other potentially infectious materials which require further evaluation or treatment.
§1910.1030(f)(5)(iii) - All other findings or diagnoses shall remain confidential and shall not be included in the written report.
Purpose: The written opinion is to ensure that the employer is provided with documentation that a medical assessment of the worker’s ability and indication to receive Hepatitis B vaccination was completed and to inform the employer regarding the worker’s Hepatitis B vaccination status. Additionally, the employer is provided with documentation that a post-exposure evaluation has been performed, and that the exposed worker has been informed of the results and any medical conditions from exposure that require further evaluation or treatment.
F. Communication of hazards to employees (§1910.1030(g))
Labels and signs (§1910.1030(g)(1))3
§1910.1030(g)(1)(i)(A) - Warning labels shall be affixed to containers of regulated waste, refrigerators and freezers containing blood or other potentially infectious material; and other containers used to store, transport or ship blood or other potentially infectious materials, except as provided in paragraph (g)(1)(i)(E), (F) and (G).
§1910.1030(g)(1)(i)(B) - Labels required by this section
shall include the following legend:
§1910.1030(g)(1)(i)(C) - These labels shall be fluorescent orange or orange-red or predominantly so, with lettering and symbols in a contrasting color.
§1910.1030(g)(1)(i)(E) - Red bags or red containers may be substituted for labels.
§1910.1030(g)(1)(i)(H) Labels required for contaminated equipment shall be in accordance with this paragraph and shall also state which portions of the equipment remain contaminated.
Signs (§1910.1030(g)(1)(ii))
§1910.1030(g)(1)(ii)(A) - The employer shall post signs
at the entrance to work areas specified in paragraph (e), HIV and HBV
Research Laboratory and Production Facilities, which shall bear the
following legend:
(Name
of the Infectious Agent)
(Special requirements for entering the
area)
(Name, telephone number of the laboratory director or
other responsible person.)
§1910.1030(g)(1)(ii)(B) - These signs shall be fluorescent orange-red or predominantly so, with lettering and symbols in a contrasting color.
Purpose: The purpose of this requirement is to alert workers to possible exposure since the nature of the material or contents will not always be readily identified as blood or other potentially infectious materials under these circumstances. Warning labels also would inform workers that appropriate barrier precautions would need to be used if occupational exposure occurs. Posting warning signs serves as a warning to workers who may otherwise not know they are entering a restricted area. Signs would also warn workers not to enter the area unless there is a need, unless the worker has been properly trained, and unless the worker also meets all other appropriate entrance requirements listed on the sign. The signs assure that workers are aware of the specific biohazard involved and of any special measures that need to be taken before entering the restricted area.
Information and training (§1910.1030(g)(2))
Upon further analysis, the requirement that employers provide training to workers under paragraph (g)(2), with the exception of (g)(2)(vii)(A), is not considered to be a collection of information. OSHA is not taking burden for this activity under Item 12 of this Supporting Statement.
Under 1910.1030(g)(2)(vii)(A), the employer must provide an accessible copy of the regulatory text of this standard and an explanation of its contents to all employees. OSHA considers this requirement to be a public disclosure of information originally supplied by the Federal government to the employer for the purpose of disclosure to the public, and therefore is not including any burden hours or costs for this provision in Item 12.
Purpose: Having a copy of the Standard readily available for workers helps to ensure that they understand all provisions of the Standard.
G. Recordkeeping (§1910.1030(h))
Medical records (§1910.1030(h)(1))
§1910.1030(h)(1)(i) - The employer shall establish and maintain an accurate record for each employee with occupational exposure, in accordance with 29 CFR 1910.1020.
§1910.1030(h)(1)(ii) - This record shall include:
§1910.1030(h)(1)(ii)(A) - The name and social security number of the employee;
§1910.1030(h)(1)(ii)(B) - A copy of the employee's hepatitis B vaccination status including the dates of all the hepatitis B vaccinations and any medical records relative to the employee's ability to receive vaccination as required by paragraph (f)(2);
§1910.1030(h)(1)(ii)(C) - A copy of all results of examinations, medical testing, and follow-up procedures as required by paragraph (f)(3);
§1910.1030(h)(1)(ii)(D) - The employer's copy of the healthcare professional's written opinion as required by paragraph (f)(5); and
§1910.1030(h)(1)(ii)(E) - A copy of the information provided to the healthcare professional as required by paragraphs (f)(4)(ii)(B)(C) and (D).
§1910.1030(h)(1)(iv) - The employer shall maintain the records required by paragraph (h) for at least the duration of employment plus 30 years in accordance with 29 CFR 1910.1020.
Training records (§1910.1030(h)(2))
§1910.1030(h)(2)(i) - Training records shall include the following information:
§1910.1030(h)(2)(i)(A) - The dates of the training sessions;
§1910.1030(h)(2)(i)(B) - The contents or a summary of the training sessions;
§1910.1030(h)(2)(i)(C) - The names and qualifications of persons conducting the training;
and
§1910.1030(h)(2)(i)(D) - The names and job titles of all persons attending the training sessions.
§1910.1030(h)(2)(ii) - Training records shall be maintained for 3 years from the date on which the training occurred.
Purpose: Medical and training records are necessary to assure that workers receive appropriate information on the hazards and effective prevention and treatment measures, as well as to aid in the general development of information on the causes of occupational illnesses and injuries involving bloodborne pathogens. Maintenance of medical records is essential because documentation is necessary to ensure proper evaluation of the worker’s immune status and for proper healthcare management following an exposure incident. Training records assure that training has taken place and can be used in determining the need to perform training in the future. They also enable the employer to assess the content and completeness of the training program in order to ensure that his or her workers have received the required training.
Availability (§1910.1030(h)(3))
§1910.1030(h)(3)(i) - The employer shall ensure that all records required to be maintained by this section shall be made available upon request to the Assistant Secretary and the Director for examination and copying.4
§1910.1030(h)(3)(ii) - Employee training records required by this paragraph shall be provided upon request for examination and copying to employees, to employee representatives, to the Director, and to the Assistant Secretary.
§1910.1030(h)(3)(iii) - Employee medical records required by this paragraph shall be provided upon request for examination and copying to the subject employee, to anyone having written consent of the subject employee, to the Director, and to the Assistant Secretary in accordance with 29 CFR 1910.1020.
Purpose: Access by employees, their representatives, and the Assistant Secretary is necessary to yield both direct and indirect improvements in the detection, treatment, and prevention of occupational disease.
§1910.1030(h)(4) Transfer of Records. The employer shall comply with the requirements involving transfer of records set forth in 29 CFR 1910.1020(h).
Paragraph (h) of §1910.1020 requires employers who cease to do business to transfer medical and exposure-monitoring records to the successor employer, who then must receive and maintain the records. If no successor employer is available, the employer must, at least three months before ceasing business, notify current workers who have records of their right to access these records.5
OSHA considers the employer’s transfer of records to a successor employer to be usual and customary communications during the transition from one employer to a successor employer. In this regard, the employer would communicate the location of all records, including worker exposure-monitoring and medical records, at the facility to the successor employer during the transfer of business operations, as a matter of usual and customary business practice.
In addition, OSHA accounts for the burden hours and costs resulting from the worker notification requirements under the Information Collection Request (ICR) for its Access to Employee Exposure and Medical Records Standard (§1910.1020), OMB Control No. 1218-0065.
Sharps injury log (§1910.1030(h)(5))
§1910.1030(h)(5)(i) - The employer shall establish and maintain a sharps injury log for the recording of percutaneous injuries from contaminated sharps. The information in the sharps injury log shall be recorded and maintained in such manner as to protect the confidentiality of the injured employee. The sharps injury log shall contain, at a minimum:
§1910.1030(h)(5)(i)(A) - The type and brand of device involved in the incident,
§1910.1030(h)(5)(i)(B) - The department or work area where the exposure incident occurred, and
§1910.1030(h)(5)(i)(C) - An explanation of how the incident occurred.
§1910.1030(h)(5)(ii) - The requirement to establish and maintain a sharps injury log shall apply to any employer who is required to maintain a log of occupational injuries and illnesses under 29 CFR 1904.
§1910.1030(h)(5)(iii) - The sharps injury log shall be maintained for the period required by 29 CFR 1904.33.
Purpose: The sharps injury log serves as a tool for identifying tasks, areas, and devices that have a high risk for sharps injuries. The information allows the employer to focus efforts toward eliminating these high risks and in device evaluation.
3. Describe whether, and to what extent, the collection of information involves the use of automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses, and the basis for the decision for adopting this means of collection. Also describe any consideration of using information technology to reduce burden.
Employers may use improved information technology whenever appropriate when establishing and maintaining the required records. OSHA wrote the paperwork requirements of the Standard in performance-oriented language (i.e., in terms of what data to maintain, not how to maintain the data). The employer may also contract the services of a healthcare professional located offsite to maintain and retain medical records.
4. Describe efforts to identify duplication. Show specifically why any similar information already available cannot be used or modified for use for the purposes described in Item A.2 above.
The information required to be collected and maintained is specific to each employer and employee involved and is not available or duplicated by another source. The information required by this Standard is available only from employers. At this time, there is no indication that any alternative source is available.
5. If the collection of information impacts small businesses or other small entities, describe any methods used to minimize burden.
The collection of information requirements of the Standard do not have a significant impact on a substantial number of small entities.
6. Describe the consequence to Federal program or policy activities if the collection is not conducted or is conducted less frequently, as well as any technical or legal obstacles to reducing burden.
The information collection frequencies specified by this Standard are the minimum that OSHA believes are necessary to ensure that the employer and OSHA can effectively monitor the exposure and health status of employees exposed to bloodborne pathogens.
Explain any special circumstances that would cause an information collection to be conducted in a manner:
• requiring respondents to report information to the agency more often than quarterly;
• requiring respondents to prepare a written response to a collection of information in fewer than 30 days after receipt of it;
• requiring respondents to submit more than an original and two copies of any document;
• requiring respondents to retain records, other than health, medical, government contract, grant-in-aid, or tax records for more than three years;
• in connection with a statistical survey, that is not designed to produce valid and reliable results that can be generalized to the universe of study;
• requiring the use of a statistical data classification that has not been reviewed and approved by OMB;
• that includes a pledge of confidentiality that is not supported by authority established in statute or regulation, that is not supported by disclosure and data security policies that are consistent with the pledge, or which unnecessarily impedes sharing of data with other agencies for compatible confidential use; or
• requiring respondents to submit proprietary trade secret, or other confidential information unless the agency can demonstrate that it has instituted procedures to protect the information's confidentiality to the extent permitted by law.
The Standard requires that employers must obtain and provide the worker with a copy of the evaluating healthcare professional’s written opinion within 15 days of the completion of the evaluation (§1910.1030(f)(5)). The 15 day provision assures that the employee is informed in a timely manner regarding information received by the employer and is consistent with other OSHA health standards.
8. If applicable, provide a copy and identify the data and page number of publication in the Federal Register of the agency's notice, required by 5 CFR 1320.8(d), soliciting comments on the information collection prior to submission to OMB. Summarize public comments received in response to that notice and describe actions taken by the agency in response to these comments. Specifically address comments received on cost and hour burden.
Describe efforts to consult with persons outside the agency to obtain their views on the availability of data, frequency of collection, the clarity of instructions and recordkeeping, disclosure, or reporting format (if any), and on the data elements to be recorded, disclosed, or reported.
Consultation with representatives of those from whom information is to be obtained or those who must compile records should occur at least once every 3 years -- even if the collection of information activity is the same as in prior periods. There may be circumstances that may preclude consultation in a specific situation. These circumstances should be explained.
As required by the Paperwork Reduction Act of 1995 (44 U.S.C. 3506(c)(2)(A)), OSHA published a notice in the Federal Register on October 7, 2014 (79 FR 60503-60505, Docket No. OSHA-2010-0047) requesting public comment on its proposed extension of the collection of requirements contained in the Respiratory Protection Standard at 29 CFR 1910.134. This notice was part of a preclearance consultation program intended to provide those interested parties the opportunity to comment on OSHA’s request for an extension by the Office of Management and Budget (OMB) of a previous approval of the collection of requirements found in the Standard. The Agency received one comment in response to the October 7, 2014 notice.
The comment was filed by Ms. Jennie L. Mayfield, President of the Association for Professionals in Infection Control and Epidemiology (APIC). In general, the commenter indicates that the collection of information associated with the Standard is necessary. The comment is discussed in additional detail below.
The commenter indicates that APIC is concerned that OSHA’s estimate of the burden associated with information collection is underestimated. The comment states, “The 2011 Exposure Prevention Information Network (EPINet) reports for sharps and body fluids reveal almost one thousand events in just thirty two sites. When considering the multiple settings where the standard applies as well as the time required by occupational health and infection prevention staff to investigate events, obtain and relay laboratory results, and manage the employee health records, the adjustment in the time estimate would seem significant. Additionally, although education is not itself information collection, it requires significant time commitments for both the employee and employer. In addition to face-to-face instruction, this would include maintaining educational records and updating employee lists. The standard also requires the assessment of new technology, an additional information collection burden which does not appear to be considered in this new estimate.”
OSHA Response: OSHA would welcome the submission of comments from APIC or other members of the public including updated data estimates for calculations in this ICR related to the number of incident events in establishments covered by the Standard. As noted in Item 12 of this Supporting Statement, OSHA relies upon the estimates from original Regulatory Impact Analysis for the Standard to make these calculations.
Also, the Agency includes costs for training records in this ICR (see discussion of paragraph 1910.1030(h)(2) in Item 12. As stated above, training delivery is not considered a collection of information under PRA-95 and thus the time and cost for training delivery is not included in this Supporting Statement (see discussion of paragraph 1910.1030(g)(2) in Item 2).
In addition, OSHA notes that the costs associated with annual exposure control plan review and update (paragraph 1910.1030 (c)(1)(iv)), including the evaluation of new technology and products, is included in Item 12 and calculated in Table 1 of this Supporting Statement. When employers review and update their exposure control plans, employers must ensure that the plan: (A) reflects changes in technology that eliminate or reduce exposure to bloodborne pathogens; and (B) includes documentation of consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure.
“APIC agrees that collecting injury data on individuals is valuable. However, the current format does not allow for easy analysis, and requires additional manipulation to create actionable data. APIC recommends that OSHA restructure its current reporting log through the development of a program which would allow easier analysis. There are several products used for event reporting, including the Centers for Disease Control and Prevention’s (CDC) databases that allow users to easily turn data into meaningful information which can help drive improvement. Using standardized established databases would improve data assessment, inform policy and procedures to help prevent future incidents, and decrease the time burden associated with this requirement.”
OSHA Response: OSHA will allow CDC forms to be used for documentation of needlestick injuries as long as the information included meets the requirements of the Standard of paragraph 1910.1030(h)(5).
“While an electronic collection system and transmission would seem optimal, many hospitals are struggling to implement with the meaningful use measures as part of the CMS Electronic Health Record (EHR) Incentive Program. An optimal system would be able to utilize data tables from human resources, laboratory, and employee health records. It is important to note, however, that various databases within an organization may not be integrated and therefore are unable to interface with each other. Instituting automated system reporting that is phased in over time would provide employers with enough time to design, test, and implement such systems.”
OSHA Response: APIC stated many hospitals are struggling to implement the Electronic Health Record (EHR) imposed by the Centers for Medicare and Medicaid Services (CMS). Each hospital may want to consider how their EHR can capture employee data as well as patient data on injuries and illness, including needlesticks for reporting, thereby eliminating manual logs and reducing their burden hours for collection of such data, as long as it meets the requirements of paragraph 1910.1030(h)(5) of the Standard. OSHA does not require submission of sharps injury logs, but each facility must maintain their logs and have them available for inspection upon request.
9. Explain any decision to provide any payment or gift to respondents, other than reenumeration of contractors or grantees.
No payments or gifts will be provided to the respondents.
10. Describe any assurance of confidentiality provided to respondents and the basis for the assurance in statute, regulation, or agency policy.
To ensure that the personal information contained in medical records remains confidential, OSHA developed 29 CFR 1913.10 to regulate access to these records.
11. Provide additional justification for any questions of a sensitive nature, such as sexual behavior and attitudes, religious beliefs, and other matters that are commonly considered private. This justification should include the reasons why the agency considers the questions necessary, the specific uses to be made of the information, the explanation to be given to persons form whom the information is requested, and any steps to be taken to obtain their consent.
None of the provisions in the Standard require the collection of sensitive information.
12. Provide estimates of the hour burden of the collection of information. The statement should:
• Indicate the number of respondents, frequency of response, annual hour burden, and an explanation of how the burden was estimated. Unless directed to do so, agencies should not conduct special surveys to obtain information on which to base hour burden estimates. Consultation with a sample (fewer than 10) of potential respondents is desirable. If the hour burden on respondents is expected to vary widely because of differences in activity, size, or complexity, show the range of estimated hour burden, and explain the reasons for the variance. Generally, estimates should not include burden hours for customary and usual business practices.
• If this request for approval covers more than one form, provide separate hour burden estimates for each form and aggregate the hour burdens.
• Provide estimates of annualized cost to respondents for the hour burdens for collections of information, identifying and using appropriate wage rate categories.
Table A
Number of Establishments
Establishment Type Total Affected
*Office of Physicians 222,638
*Office of Dentists 131,179
*Nursing Homes 21,897
*Hospitals 6,930
*Medical and Dental Labs 19,932
*Home Health 9,623
*Hospices 651
*Hemodialysis 391
*Drug Rehabilitation 744
*Government Clinics 10,893
*Blood/Plasma/Tissue Centers 1,357
*Residential Care 12,890
Personnel Services 1,348
Funeral Services 20,795
Health Units in Industry 202,540
Research Labs 1,453
Linen Services 1,471
Medical Equipment Repair 1,076
Law Enforcement 7,595
Fire and Rescue 4,905
Correctional Facilities 4,900
Lifesaving 100
Schools 6,321
Waste Removal 50
________
691,669
Source: Occupational Safety and Health Administration, Office of Regulatory Analysis
*Industries that are included in SIC 80 Health care.
Classification of Employees
In order to prepare its regulatory impact analysis, OSHA chose to group employees into four groups depending upon their duties. Group A employees are those who have direct patient health care responsibilities, such as physicians and nurses. Group B employees are those employed in laboratories or who have emergency response duties, such as emergency medical technicians, fire fighters, and law enforcement officers. Group C employees are housekeepers and janitors. Group D employees are other workers, such as drivers, service workers, and social workers.
Many of the Tables in Appendix A, “Bloodborne Pathogens Standard Burden Hour Calculation Tables” use these Groups to calculate burden hours and costs.
TABLE B
Number of Affected Employees, Job Turnover Rates, and
Occupational Turnover Rates by Industry and Job Classification
` |
Number of Affected Employees |
Job Turnover Rate |
Occupational Turnover Rate |
Offices of Physicians Category A C D |
1,270,003 9,147 91,461 |
22.8 31.6 21.8 |
6.9% 9.8% 12.9% |
Office of Dentists Category A C |
471,012 4,514 |
26.8 31.6 |
1.6% 9.8% |
Nursing Homes Category A C D |
700,374 45,1867,531 |
49.9 31.6 31.6 |
24.8% 9.8% 9.8% |
Hospitals Category A B C |
2,371,307 202,612 315,174 |
27.2 21.8 31.6 |
14.7% 12.9% 9.8% |
Medical and Dental Labs Category A C D |
234,940 1,809 203,988 |
21.7 31.6 31.6 |
12.9% 9.8% 9.8% |
Home Health Category A C D |
288,088 4,259 8,943 |
36.3 31.6 36.3 |
22.3% 9.8% 22.5% |
Hospices Category A C D |
10,565 154 27 |
36.3 31.6 36.3 |
22.5% 9.8% 22.5% |
Hemodialysis Category A C D |
4,964 87 230 |
25.5 31.6 21.8 |
15.4% 22.5% 12.9% |
Drug Rehabilitation Category A C D |
6,067 149 506 |
25.5 31.6 21.8 |
15.4% 22.5% 12.9% |
Government Clinics Category A C D |
52,156 381 3,808 |
22.8 31.6 21.8 |
13.5% 9.8% 12.9% |
Blood/Plasma/Tissue Cntrs. Category A C D |
33,828 372 725 |
21.8 31.6 36.3 |
12.9% 9.8% 22.5% |
Residential Care Category A C D |
71,542 1,975 11,723 |
49.6 31.6 36.3 |
24.3% 9.8% 9.8% |
Personnel Services Category A D |
61,387 102,090 |
100.0 31.6 |
8.7% 9.8% |
Funeral Services Category A C D |
53,377 2,845 3,385 |
21.8 31.6 31.6 |
12.9% 9.8% 9.8% |
Health Units in Industry Category A B D |
34,184 141,051 3,497 |
31.7 21.8 31.6 |
19.5% 9.8% 12.9% |
Research Labs Category A C D |
87,484 1,315 352 |
21.8 31.6 21.8 |
12.9% 9.8% 12.9% |
Linen Services Category D |
58,840 |
54.0 |
9.8% |
Medical Equipment Repair Category A B C D |
473 200 5,152 360 |
38.3 38.3 21.8 21.8 |
22.5% 12.9% 12.9% 22.5% |
Law Enforcement Category A B C D |
471,070 1,746 4,019 47,637 |
10.1 21.8 31.6 10.1 |
7.8% 9.8% 7.8% 12.9% |
Fire and Rescue Category A B D |
172,965 210,807 2,735 |
21.8 8.5 38.3 |
12.9% 22.5% 7.8% |
Correctional Facilities Category A B C D |
21,671 214,315 18,806 56,077 |
31.7 41.0 31.6 29.1 |
19.5% 12.9% 17.7% 7.8% |
Lifesaving Category A |
5,000 |
21.8 |
12.9% |
Schools Category A D |
23,514 17,848 |
25.0 36.3 |
15.0% 22.5% |
Waste Removal Category A |
13,300 |
36.3 |
22.5% |
To update the number of affected employees, the Agency, using the original RIA estimates, determined the number of employees per category, per establishment. The number of employees per category, per establishment, was multiplied by the number of establishments as listed in Table A to determine the total number of affected employees in the various job categories.
The Agency determined average wage rates using hourly earnings, including benefits, to represent the cost of employee time. For the relevant occupational categories, mean hourly earnings from May 2013 National Industry-Specific Occupational Employment and Wage Estimates by the Bureau of Labor Statistics have been adjusted to reflect the fact that fringe benefits comprise about 29.9% of total compensation in the private sector. Since wages are the remaining 70.1% of employee compensation wages are multiplied by 1.43 (1/0.701) to estimate full employee hourly compensation. The costs of labor used in this analysis are therefore estimates of total hourly compensation. These hourly wages6 are:
Manager/Supervisor $64.12
Employee $33.58
Clerical employee $23.27
Personnel Training and $44.76
Labor Relations Specialist and
Counselor
Infection Control Practitioner $47.36
and Healthcare Provider
Medical Personnel (Category A) $23.27
Laboratory Technician and $27.60
Emergency Response Personnel
(Category B)
Housekeepers, Janitors $17.25
(Category C)
Service Workers (Category D) $23.22
A. Exposure control plan
(1) Exposure control plan (§1910.1030(c)(1)-(2))
There are four key elements that constitute the exposure control plan: the exposure determination, the schedule and method of implementation of the provisions of the Standard, employee solicitation and the procedure for evaluating exposure incidents.
The exposure determination is the identification and documentation of those tasks and procedures where occupational exposures may take place and the employees who perform those tasks and procedures. This includes a list of all job classifications where all employees have occupational exposure and a list of job classifications in which some but not all employees have occupational exposure and the tasks and procedures that they perform that place them at risk for occupational exposure. The employer must provide a schedule and method of implementation of the provisions of the Standard.
Paragraph (c)(1)(iv) requires the employer to annually review and update their exposure control plan. When employers review and update their exposure control plans, employers must ensure that the plan: (A) reflects changes in technology that eliminate or reduce exposure to bloodborne pathogens; and (B) includes documentation of consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure.
The burden hours associated with the development of the exposure control plan are for new employers to develop their exposure control plan and existing employers to update their exposure control plan. To develop plans, hospitals take 16 hours; medical and dental labs take 8 hours; and, physicians, dentists and residential care 4 hours. OSHA estimates that hospitals will require 8 hours annually to review and update their plans. All other sectors take 2 hours to review and update their exposure control plans. The total burden hours for the written exposure control plan are 1,424,917. The assumptions made and the breakdown by type of facility are found in Table 1 in the appendix7 to this document.
(2) Exposure control plan – Documentation required by the Needlestick Prevention Act
Employers must document consideration and implementation of appropriate commercially available and effective safer medical devices designated to eliminate or minimize occupational exposure and employee solicitation in the exposure plan. These employers are likely to be in SIC Code 80, as noted in Table A. The effort for this documentation is 15 minutes (.25 hour) of managerial time earning $64.12 an hour.
Burden hours: 439,115 establishments x .25 hour = 109,779 hours
Cost: 109,779 hours x $64.12 = $7,039,029
(3) Employee Solicitation (c)(1)(v)
Employers who are required to establish an exposure control plan must solicit input from non-managerial employees responsible for direct patient care who are potentially exposed to injuries from contaminated sharps in the identification, evaluation, and selection of effective engineering and work practice controls and shall document the solicitation in the “Exposure control plan.”
The overwhelming majority of establishments that have employees who are responsible for direct patient care and who are potentially exposed to injuries from contaminated sharps are in SIC code 808, Health Services (1997 County Business Patterns (SIC), U.S.
Census Bureau). The 1997 data is the most recent data available using the SIC reporting system, however, many of the establishments in SIC 80 are now counted in NAICS sector 62 Healthcare and social assistance. Using comparable 6-digit NAICS industries and data reported by the 2011 County Business Patterns the Agency estimates there are 439,115 establishments that must solicit input from non-managerial employees.
OSHA estimates that the initial solicitation requires 15 minutes (.25 hour) of managerial time.
Burden hours: 439,115 establishments x .25 hour = 109,779 hours
Costs: 109,779 hours x $64.12 = $7,039,029
(4) Employee Response (c)(1)(v)
The burden hours and costs associated with the employee response will vary with the number of employees and the response rate to the initial solicitation. According to the 2011 County Business Patterns, there were 12,799,754 individuals employed in the relevant NAICS industries in 2011.OSHA estimates that it takes 15 minutes (.25 hour) of employee time to respond to the solicitation and that approximately 33% or 4,223,919 individuals will respond. OSHA uses a wage rate of $33.58.
Burden hours: 4,223,919 individuals x .25 hour = 1,055,980 hours
Costs: 1,055,980 hours x $33.58 = $35,459,808
B. Housekeeping (§1910.1030(d)(4)(i)) Burden hours: 0
The employer must determine and implement an appropriate written schedule for cleaning and method of disinfection based on the location within the facility, type of surface to be cleaned, type of soil present, and tasks or procedures being performed. Since it is customary for facilities to have a written housekeeping plan, the Bloodborne Pathogens Standard would not impose a significant paperwork burden.
C. Laundry (§1910.1030(d)(4)(iv)(A)(2)) Burden hours: 0
Labeling requirements required by this paragraph are currently in place and are being followed by the facilities covered by Bloodborne Pathogens Standard; therefore, there is no additional burden from the labeling procedures.
D. HIV/HBV research laboratories and production facilities (§1910.1030(e)(2)(ii)(M))
Burden hours: 0
The employer must adopt or prepare a biosafety manual. The biosafety manual is a usual and customary part of any viral research program where harmful microorganisms are used on a routine basis or in any production facility where large quantities of these microorganisms are being cultured (grown), for example, in the production of viral vaccines. Therefore, there are no additional burden hours.
E. Hepatitis B Vaccine; Post exposure follow-up (§1910.1030(f))
(1) Hepatitis B Vaccination Burden hours: 380,856
The Standard requires employers to make available the hepatitis B vaccine to all employees who have occupational exposure unless: the employee has previously received the complete hepatitis B vaccination series, antibody testing reveals that the employee is immune, or the vaccine is contraindicated for medical reasons. Since the Standard has been in effect since December, 1991, most employees with occupational exposure have already been offered the vaccine. The Agency expects that most vaccinations would be offered to employees who are newly entering the field. All newly hired employees who have contact with patients or blood and are at an ongoing risk for injuries with sharp instruments or needle sticks must be tested for the antibody to hepatitis B surface antigen, one to two months after completion of the 3-dose vaccination series. Since this procedure would require employee time to be vaccinated and health care professional time to administer the vaccine, we have prepared two tables. The assumptions made and the breakdowns by type of facility are found in Table 2 for employee’s time and Table 3 for the healthcare worker time. Table 2 estimates the total burden for all employees to receive HBV vaccinations and to be tested for hepatitis B surface antigen is 258,565. The total burden hours for health care professionals in Table 3 are 122,291.
(2) Antibody testing of source individuals Burden hours: 47,875
The Standard requires that if an exposure incident occurs then the employer is to contact the individual whose blood is the source of the exposure (source individual) and, after legal consent is obtained, test the source individual to determine HIV and HBV infectivity. The assumptions for determining the burden hours for the health care professional to provide source testing for both HIV and HBV are in Table 4. Burden hours for the healthcare professional to provide HIV source testing are estimated to be 42,565 hours, while source testing for HBV is estimated to be 5,310 hours (Table 4, Cont’d).
(3) HBV antibody testing for workers Burden hours: 17,103
The Standard requires that the employer provide post exposure evaluation and follow up according to the recommendations of the US Public Health Service current at the time the evaluation and follow up takes place. The employer must obtain consent of the exposed employee to collect and test the exposed employee's blood to establish a baseline sample (HBV). The current CDC guideline states that within 24 hours, post exposure prophylaxis with hepatitis B immune globulin (HBIG) and/or vaccine should be administered when indicated (e.g., after percutaneous or mucous membrane exposure to blood known or suspected to be HbsAg (hepatitis B surface antigen) positive). The assumptions made and the breakdown by type of facility is found in Tables 5-12 in the appendix to this document.
Tables 5 and 7 estimate that it will take 11,402 hours for vaccinated workers, and 1,617 hours for non-vaccinated workers, respectively, to receive HBV post exposure blood tests. Table 6 estimates that it takes health care professionals 3,387 hours to administer the HBV post exposure blood tests to vaccinated workers and Table 8 estimates that health care workers will take 281 hours to administer the HBV post exposure blood tests to non-vaccinated workers.
Tables 9 through 12 determine burden hours and costs for administering the Hepatitis B Immune Globulin (HBIG). Table 9 estimates a total of 12 hours for vaccinated workers to received HBIG and Table 10 estimates it takes health care professionals a total of 4 hours to administer HBIG to vaccinated workers. Table 11 estimates a total of 335 hours for non-vaccinated workers to receive HBIG and Table 12 estimates it takes health care professionals a total of 65 hours to administer HBIG to non-vaccinated workers.
(4) HIV serologic testing and Post exposure prophylaxis (PEP) for exposed workers
The Standard requires that the employer provide post exposure evaluation and follow up according the current recommendations of the US Public Health Service at the time the evaluation and follow up takes place. The employer must obtain the exposed employee’s consent to collect and test the exposed employee's blood to establish a baseline sample. The current Center for Disease Control (CDC) recommendation for healthcare workers9 (HCW) who have occupational exposure to blood or other body fluids that may contain HIV virus includes post exposure prophylaxis (PEP) that includes a basic regimen of two drugs for four weeks and in most cases an “expanded” regimen that includes a third drug.
Tables 13 and 14 calculate the burden hours for workers and healthcare professionals respectively. The hours for administration of HIV antibody testing for workers are 280,022 hours and for the health care professionals are 81,789 hours.
To estimate the burden hours and costs for PEP, OSHA estimated 8,852 healthcare workers10 would be eligible for the PEP, and it will take one hour initially and at least one hour for follow-up visits. This includes travel time. The total burden hours for health care worker’s PEP are 17,704 hours. OSHA estimates that HCP earns $47.36 an hour, resulting in a wage hour cost of $838,461.
(5) Counseling for exposed workers Burden hours: 619,983
The Standard requires that post exposure counseling be provided to employees who have had an exposure incident. This information is presented in a single table that accounts for both employee and counselor time. The assumptions made, and the breakdown by type of facility are found in Table 15 in the appendix of this document.
Information provided to healthcare professionals Burden hours: 118,968
Information concerning the nature of the exposure incident must be provided to the physician so that the health care professional will know what actions to take in the follow up care. The Agency has determined the hours by multiplying the number of exposure incidents (1,189,681) by 6 minutes.
OSHA assumes a clerk earning $23.27 will provide the information to the physician; therefore the total cost is $2,768,385.
(7) Healthcare professionals written opinion Burden hours: 118,968
The standard requires the employer to obtain and provide the employee with a copy of the evaluating healthcare professional’s written opinion within 15 days of the completion of the evaluation. We have determined the hours by multiplying the number of exposure incidents (1,189,681) by 6 minutes. OSHA assumes a clerk earning $23.27 will provide the information to the physician; therefore the total cost is $ 2,768,385.
F. Communication of hazards to employees
(1) Labels and signs (§1910.1030 (e)(2)(ii) and (g)(1)(i) and (g)(1)(ii)) Burden hours: 0
Paragraph (e)(2)(ii), requires that HIV and HBV research laboratories and production facilities that send contaminated materials to a site away from the work area, place the materials in a durable, leak proof container that is labeled or color coded. When infectious materials or infected animals are in the work area, a hazard warning sign, with the universal biohazard symbol, must be posted on all access doors. Paragraph (g)(1)(ii) requires the sign contain the biohazard symbol, the word "biohazard", the name of the infectious agent, special requirements for entering the area, and the name and telephone number of the laboratory director or other responsible person. They must be fluorescent orange-red or predominantly so, with lettering and symbol in a contrasting color. Since these signs have been permanently mounted there is no additional burden.
Paragraph (g)(1)(i) requires that employers place warning labels on containers of regulated waste, refrigerators and freezers containing blood or other potentially infectious material; and other containers used to store, transport or ship blood or other potentially infectious materials, except as provided in paragraph (g)(1)(i)(E), (F) and (G). The requirements for the color of the labels are identical for those for the signs except that red bags or red containers may be substituted for labeled containers for regulated wastes. There are no burden hours unique for labeling since containers used to transport or store blood or regulated wastes are now manufactured and widely available with labels and symbols already affixed to them.
G. Recordkeeping (§1910.1030 (h) (1) - (4)) Total hours: 1,098,058
(1) Medical Records Burden hours: 935,957
The Standard requires the employer to maintain medical surveillance records for each employee in accordance with 29 CFR 1910.1020. These confidential records must contain the employee's name and social security number, a copy of each employee's hepatitis B vaccination record, the circumstances of any occupational exposure incident, results of medical testing as they relate to the employee's ability to receive vaccination or post exposure evaluation following an exposure incident; a copy of the physician's written opinion; and a copy of the information provided to the physician. The records must be maintained for at least the duration of each employee's period of employment plus 30 years. The time required for medical recordkeeping is based on the need to establish medical records for new hires and to update existing medical records for current employees. The assumptions and breakdown by facility type are found in Table 18 in the appendix to this document.
(2) Training Records Burden hours: 159,945
The Standard requires the employer to maintain training records. These records must contain the following information: the dates of the training sessions; the contents or a summary of the contents of the training sessions; the names and qualifications of persons conducting the training; and the names and job titles of all persons attending the training. These records do not have to be individual records kept in each employee's personnel folder but can be created and maintained for each training session that may provide training for many employees. These records must be maintained for 3 years. The assumptions and breakdown by facility type are found in Table 19 in the appendix to this document.
(3) Employee Access Burden hours: 1,904
The Standard requires that employee medical records also be made available to anyone having the written consent of the employee. OSHA assumes that the records that will be requested by 2% of employees who have had an exposure incident, and that it would take a clerical, earning $23.27 per hour 5 minutes (.08 hour) to provide access. The calculation of burden hours is based on number of exposures per year (1,189,681) x 2% x 0.08 hours.
Costs then equals 1,904 hours x $23.27 = $44,306
(4) Federal Access Burden hours: 0
The Standard states that the exposure control plan must be made available to the Assistant Secretary and the Director for examination and copying §1910.1030(c)(1)(v). Similarly, section (h)(3)(i) states "the employer shall ensure that all records required to be maintained by this section shall be made available upon request to the Assistant Secretary and the Director for examination and copying.” Also, medical records (§1910.1030(h)(3)(iii)), and training records (§1910.1030 (h)(3)(ii)), shall be made available to the Assistant Secretary and the Director for examination and copying in accordance with 29 CFR 1910.1020.
Usually, OSHA will request access to records during compliance inspections. Information collected by the Agency during the investigation is not subject to the PRA under 5 CFR 1320.4(a)(2). Therefore, OSHA takes no burden or cost in Items 12 and 14 of this Supporting Statement
(5) Sharps Injury Log Burden hours: 47,213
Employers, who are required to maintain an occupational injuries and illness log under 29 CFR 1904, must establish and maintain a sharps injury log for the recording of percutaneous injuries from contaminated sharps. The information in the sharps injury log must be recorded and maintained in a manner as to protect the confidentiality of the injured employee. The sharps injury log must contain the following: (A) the type and brand of device involved in the incident, (B) the department or work area where the exposure incident occurred, and (C) an explanation of how the incident occurred.
The burden hours and costs attributable to the log are based on the number of needlestick and sharp injuries and the time to record the required information. OSHA estimates there are 590,164 needlestick and sharps injuries annually11, and it takes a staff member with a skill level of a Personnel Training and Labor Specialist, with an hourly wage rate of $44.76, five minutes (.08 hour) to collect the data and enter it onto a separate log.
The format of the sharps injury log is not specified. The employer is permitted to determine the format in which the log is maintained (e.g. paper or electronic), and may include information in addition to that required by the standard, so long as the privacy of the injured workers is protected. Many employers already compile reports of percutaneous exposure incidents in a variety of ways. Existing mechanisms for collecting this information will be considered sufficient to meet the requirements of the standard for maintaining a sharps injury log, provided that the information gathered meets the minimum requirements specified in the standard, and the confidentiality of the injured employee is protected.
Burden hours: 590,164 cases x .08 hour = 47,213 hours
Cost: 47,213 hours x $44.76 = $2,113,254
Table C
Summary of Burden Hours, Costs and Responses
Collection of Information |
Existing Burden Hours |
Requested Burden Hours |
Reasons for Change |
Cost Under Item #12 |
(A) Exposure control plan |
|
|
|
|
(1) Written Plan (Table 1) |
1,520,338 |
1,424,917 |
Changes to the industry profile. |
$67,484,092 |
(2) Documentation required by the Needlestick Prevention Act |
105,723 |
109,779 |
An increase in the number of facilities in the healthcare sector. |
$7,039,029 |
(3) Employee Solicitation |
105,723 |
109,779 |
An increase in the number of facilities in the healthcare sector. |
$7,039,029 |
(4) Employee Response
|
902,747 |
1,055,980 |
An increase in the number of employees. |
$35,459,808 |
(B) Housekeeping |
0 |
0 |
No change. |
0 |
(C) Laundry |
0 |
0 |
No change. |
0 |
(D) HIV/HBV research laboratories and production facilities. |
0 |
0 |
No change. |
0 |
(E) Hepatitis B Vaccination and post-exposure evaluation and follow-up |
|
|
|
|
(1) Hepatitis B Vaccination Table 2 (Employee time) |
240,330 |
258,565 |
An increase in the number of employees. |
$11,574,066 |
Table 3 (Health Care Professional Time) |
6,618,653 |
122,291 |
Correction of calculations in Table 3 in the Appendix which previously included some capital costs in the calculation for burden hours. |
$5,791,702 |
(2) Antibody Testing Source Individuals Table 4 HIV Source Testing Health Care Time |
39,650 |
42,565 |
Adjustment of calculations in Table 4 in the appendix to correct administrative errors. |
$2,015,879 |
Table 4 Cont’d HBV Source Testing |
5,310 |
5,310 |
No change. |
$225,454 |
(3) HBV Antibody Testing for workers Table 5 HBV Antibody Testing for Vaccinated Worker (Employee Time) |
11,402 |
11,402 |
No change. |
$264,094 |
Table 6 HBV Testing for Vaccinated Workers (Health Care Professional Time) |
3,397 |
3,387 |
Changes due to rounding. |
$160,407 |
Table 7 HBV Antibody Testing for Non-Vaccinated Workers (Employee Time) |
1,622 |
1,617 |
Changes due to rounding. |
$76,875 |
Table 8 HBV Antibody Testing for Non-vaccinated Workers (Health Care Professional Time) |
282 |
281 |
Changes due to rounding. |
$13,310 |
Table 9 Hepatitis B Immune Globulin (HBIG) Vaccinated Workers (Employee Time) |
12 |
12 |
No change. |
$388 |
Table 10 HBIG: Vaccinated Workers (Health Professional Time) |
34 |
4 |
Calculations adjusted to correct administrative errors. |
$193 |
Table 11 HBIG Non Vaccinated Workers (Employee Time) |
336 |
335 |
Changes due to rounding. |
$15,796 |
Table 12: HBIG Non-vaccinated Workers (Health Care Professional Time) |
59 |
65 |
Changes due to adjustment of calculations in Table 12 to correct administrative errors.. |
$3,077 |
(4) HIV serologic testing and Post-exposure prophylaxis (PEP) exposed workers |
17,704 |
17,704 |
No change. |
$838,461 |
Table 13 HIV Antibody Tests (Employee Time) |
280,370 |
280,022 |
Changes due to adjustment of calculations in Table 13 to correct administrative errors |
$9,403,139 |
Table 14 (HIV Antibody Tests Health Care Professional Time) |
82,118 |
81,789 |
Changes due to adjustment of calculations in Table 14 to correct administrative errors. |
$3,873,527 |
(5) Counseling for exposed Workers (Table 15)
|
551,729 |
619,983 |
Changes due to an increase in the number of employees in the industry profile. |
$24,284,732 |
(6) Information provided to the healthcare professional |
118,968 |
118,968 |
No change. |
$2,768,385 |
(7) Healthcare professionals written opinion |
118,968 |
118,968 |
No change. |
$2,768,385 |
(F) Communication of hazards to employees |
|
|
|
|
(1) Labels and signs |
0 |
0 |
No change. |
0 |
(2) Information and Training |
0 |
0 |
No change. |
0 |
Table 16 (Training new hires) |
1,495,569 |
0 |
See Item 2. |
0 |
Table 17 Retraining in –service employees |
1,203,667 |
0 |
See Item 2. |
0 |
(G) Recordkeeping |
|
|
|
|
(1) Medical records (Table 18: Medical records) |
906,682 |
935,957
|
Changes due to an increase in affected employees in the industry profile. |
$21,779,718
|
(2) Training Records (Table 19: Updating or creating training records) |
138,017 |
159,945 |
Changes due to an increase in affected employees in the industry profile. |
$3,721,923 |
(3) Availability |
1,903 |
1,904 |
Changes due to rounding. |
$44,306 |
(4) Federal access |
252 |
0 |
Usually, OSHA will request access to records during compliance inspections. Information collected by the Agency during the investigation is not subject to the PRA under 5 CFR 1320.4(a)(2). |
$0 |
(5) Sharps injury log |
47,213 |
47,213 |
No change |
$2,113,254 |
|
|
|
|
|
TOTALS |
14,518,778 |
5,528,742 |
|
$209,062,050 |
13. Provide an estimate of the total annual cost burden to respondents or recordkeepers resulting from the collection of information. (Do not include the cost of any hour burden shown in Items 12 and 14).
• The cost estimate should be split into two components: (a) a total capital and start‑up cost component (annualized over its expected useful life); and (b) a total operation and maintenance and purchase of services component. The estimates should take into account costs associated with generating, maintaining, and disclosing or providing the information. Include descriptions of methods used to estimate major cost factors including system and technology acquisition, expected useful life of capital equipment, the discount rate(s), and the time period over which costs will be incurred. Capital and start‑up costs include, among other items, preparations for collecting information such as purchasing computers and software; monitoring, sampling, drilling and testing equipment; and record storage facilities.
• If cost estimates are expected to vary widely, agencies should present ranges of cost burdens and explain the reasons for the variance. The cost of purchasing or contracting out information collection services should be a part of this cost burden estimate. In developing cost burden estimates, agencies may consult with a sample of respondents (fewer than 10), utilize the 60‑day pre‑OMB submission public comment process and use existing economic or regulatory impact analysis associated with the rulemaking containing the information collection, as appropriate.
• Generally, estimates should not include purchases of equipment or services, or portions thereof, made: (1) prior to October 1, 1995, (2) to achieve regulatory compliance with requirements not associated with the information collection, (3) for reasons other than to provide information or keep records for the government, or (4) as part of customary and usual business or private practices.
Certain employers will incur costs for the various medical requirements contained in the Standard. The costs to respondents are reflected in Tables 3, 4, 6, 8, 10, 12, and 14. The table below summarizes the costs.
In addition, employers will incur the cost of providing post exposure prophylaxis (PEP) to employees who have had occupational exposure to blood, and other body fluids, that may contain HIV.
There are a host of drugs that can be prescribed by the doctors depending on the employee's personal health and drug tolerance. Since the costs of these drugs can vary significantly, the Agency based the cost estimate on the most frequently used drugs.12
OSHA estimates it costs $2,843 per employee to provide the 4-week PEP. For purposes of estimating costs, OSHA assumes each employee will receive an expanded regiment which consists of Combivir and a protease inhibitor. Based on the 2013 VA Drug Pharmaceutical Prices Federal Supply Schedule, OSHA estimates one tablet of Combivir costs $9.23, which must be taken twice a day for 28 days resulting in a cost of $517. One tablet of a protease inhibitor costs $9.23. Three tablets must be taken three times a day for 28 days, costing $2,326. OSHA estimated that 8,852 employees may be provided PEP at a cost of $2,843 per employee, totaling $25,166,236.
CHANGES IN COSTS
Medical Provision |
Existing Costs |
Proposed Costs |
Hepatitis B Vaccination13 (Table 3) |
$9,641,841 |
$10,403,212 |
HIV Testing - (Table 4) |
$2,603,427 |
$2,623,678 |
HBV Source Testing - (Table 4 (Cont’d)) |
$1,201,382 |
$1,201,382 |
HBV Antibody Testing for Vaccinated Workers (Table 6) |
$371,183 |
$371,183 |
HBV Antibody Testing for Non Vaccinated Workers (Table 8) |
$65,367 |
$70,858 |
Hepatitis B Immune Globulin Vaccinated Workers (Table 10) |
$26,919 |
$2,782 |
Hepatitis B Immune Globulin Non Vaccinated Workers (Table 12) |
$99,024 |
$99,018 |
HIV Antibody Tests (Table 14) |
$6,161,339 |
$6,155,548 |
PEP to Employees |
$14,172,052 |
$25,166,236 |
TOTAL COST |
$34,342,534 |
46,093,897 |
14. Provide estimates of annualized cost to the Federal government. Also, provide a description of the method used to estimate cost, which should include quantification of hours, operational expenses (such as equipment, overhead, printing, and support staff), and any other expense that would not have been incurred without this collection of information. Agencies also may aggregate cost estimates from Items 12, 13, and 14 in a single table.
There are no costs to the Federal Government associated with this collection of information.
15. Explain the reasons for any program changes or adjustments.
The Agency is requesting an adjustment decrease in the number of burden hours from 14,518,778 to 5,528,742 hours (a decrease of 8,990,036 hours). The Agency updated the industry profile and estimates that the number of facilities and employees affected by the Standard has increased. However, the Agency calculates an overall decrease in burden hours. This is primarily related to an administrative error found in the previous ICR which overestimated the burden hours and costs related to health care professional time associated with the Hepatitis B vaccination. Also, part of the decrease in burden hours is related to the determination that the training provision of the Standard, although still in effect, is not considered to be a collection of information. The operation and maintenance cost increased from $34,342,534 to $46,093,897 due to the increase in medical costs (administration of the Hepatitis B Vaccine and HIV antibody tests, and the PEP treatment).
The industry profile was updated using the 2011 County Business Patterns where OSHA’s sectors, originally based on the 1997 County Business Patterns and 1987 SIC, could be reasonably represented by a selection of 2007 NAICS industries. For government entities, the 2011 Quarterly Census of Employment and Wages was used where 2007 NAICS industries could reasonably represent the original industry sectors. This resulted in an increase in affected facilities from 666,933 to 691,669. The agency increased employment relative to the change in the number of affected facilities resulting in an increase of affected employees from 7,551,260 to 8,720,108.
The updated industry profile contributed to changes in the number of burden hours and total costs of the exposure control plan, Hepatitis B vaccination and post-exposure evaluation and follow-up, and recordkeeping requirements in Item 12. For Item 13, updates to the industry profile contributed to changes to Tables 3 and 4 (the costs for the administration of the Hepatitis B Vaccine and HIV antibody tests).
Other causes contributing to changes to Item 12 burden hours and costs include adding rounding to the calculations in various tables and corrections to some administrative errors in the calculations in the tables in the Appendix. One key correction was to Table 3 which counted the Item 13 costs of the vaccinations as burden hours. This adjustment resulted in a decrease of roughly 6 million burden hours.
The Agency updated the cost of PEP treatment using the 2013 VA Pharmaceutical Drug Pricing resulting in a change in the cost per employee from $1,601 to $2,843. Corrections to the calculations in Tables 4 cont, 8, and 10 caused the changes for the administration of HBV source tests, HBV antibody tests for non-vaccinated workers, and HBIG tests for vaccinated workers.
Usually, OSHA will request access to records during compliance inspections. Information collected by the Agency during the investigation is not subject to the PRA under 5 CFR 1320.4(a)(2). Therefore, OSHA takes no burden or cost in Items 12 and 14 of this Supporting Statement
16. For collections of information whose results will be published, outline plans for tabulation, and publication. Address any complex analytical techniques that will be used. Provide the time schedule for the entire project, including beginning and ending dates of the collection of information, completion of report, publication dates, and other actions.
OSHA will not publish the information collected under the Standard.
17. If seeking approval to not display the expiration date for OMB approval of the information collection, explain the reasons that display would be inappropriate.
OSHA lists current valid control numbers in §§1910.8, 1915.8, 1917.4, 1918.4, and 1926.5 and publishes the expiration date in the Federal Register notice announcing OMB approval of the information-collection requirement. (See 5 CFR 1320.3(f)(3).) OSHA believes that this is the most appropriate and accurate mechanism to inform interested parties of these expiration dates.
18. Explain each exception to the certification statement.
OSHA is not seeking an exception to the certification statement.
B. COLLECTIONS OF INFORMATION EMPLOYING STATISTICAL METHODS.
This Supporting Statement does not contain any collection of information requirements that employ statistical methods.
1 The purpose of this supporting statement is to analyze and describe the burden hours and costs associated with provisions of the Standard that contain paperwork requirements; this supporting statement does not provide information or guidance on how to comply with, or how to enforce the Standard.
2 “Occupational exposure” means reasonably anticipated skin, eye, mucous membrane, or parenteral contact with blood or other potentially infectious materials that may result from the performance of an employee’s duties.
3Paragraphs (d)(2)(xiii)(A), Containers for storage, transportation and shipping; and (d)(2)(ix)(A), Contaminated equipment require labels in accordance with (g)(1)(i) and (g)(1)(i)(H) respectively. Also paragraph (d)(4)(iii), Regulated Waste, contains several labeling requirements to be in accordance with (g)(1)(i) of the standard. Also, see “Laundry,” above, for discussion of labeling requirements.
4 Usually, OSHA will request access to records during compliance inspections. Information collected by the Agency during the investigation is not subject to the PRA under 5 CFR 1320.4(a)(2). Therefore, OSHA takes no burden or cost in Items 12 and 14 of this Supporting Statement
5 Upon a thorough review of this ICR, the Agency determined that these provisions were not addressed in previous ICRs.
6 These wages are based on the 2013 OES (http://www.bls.gov/oes/2013/may/oes_nat.htm ) mean hourly wages for management occupations (11-0000), industry total (00-0000), administrative employees (43-0000), and labor relations specialists (13-1075) for the Medical services sector (NAICS 62). The wages for the infection control practitioner and healthcare provider, laboratory technician/emergency response personnel, service worker, janitor, and general medical personnel are based on mean hourly wages reported for all industry sectors for the following occupation codes: 29-9011 (Healthcare Practitioners and Technical Occupations (Major Group)), 29-2012 (Medical and Clinical Laboratory Technicians), 53-0000, 37-2011, and 29-0000, respectively. All wage rates were inflated based on a fringe benefit share of 29.9% estimated in ECEC’s December 2013 press release.
7 Bloodborne Pathogens Standard ICR Tables 2014 provided in ROCIS Supplementary Documents.
8The Offices of Other Practioners was not included in SIC 80 in the Agency’s industry profile.
9HCW is defined by CDC as any person (e.g., an employee, student, contractor, attending clinician, public safety worker, or volunteer) whose activities involve contact with patients or with blood or other body fluids from patients in a health-care or laboratory setting.
10 OSHA has adopted the International Health Care Worker Safety Center (IHCSWS) estimate of 590,164 needlestick and sharp injuries occur annually. Of these about 1-2% of these involve source patients who are HIV positive. For purposes of calculating burden hours and costs OSHA has assumed 1.5%.
11OSHA uses The International Health Care Worker Safety Center estimate of 590,164 annual needlestick and sharps injuries.
12 National Clinician's Postexposure Hotline, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC).
13The cost for antibody to hepatitis B surface antigen is estimated to be $80.00 to $100.00 per person. For purposes of estimating burden hours and costs, OSHA estimated the cost to be $90.00.
File Type | application/msword |
File Title | SUPPORTING STATEMENT FOR THE INFORMATION COLLECTION |
Author | OSHA_User |
Last Modified By | Showalter, Rachel - OSHA |
File Modified | 2015-03-13 |
File Created | 2015-03-13 |